Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Adverse Cardiac Event (MACE)”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableEnrolling By InvitationNCT07130968
What this trial is testing

Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform

Who this might be right for
MACECardiac DeathUnplanned Repeat Revascularization+3 more
Guangdong Provincial People's Hospital 200,000
Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Post-approval studies (Phase 4)Study completedNCT01431495
What this trial is testing

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)

Who this might be right for
Coronary Disease
Les Laboratoires des Médicaments Stériles 219
Not applicableActive Not RecruitingNCT03471845
What this trial is testing

RESOLUTE ONYX China Single Arm Study

Who this might be right for
Ischemic Heart DiseaseStenotic Coronary LesionCardiovascular Diseases+2 more
Medtronic Vascular 591
Not applicableStudy completedNCT02533128
What this trial is testing

Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery

Who this might be right for
HypotensionPostoperative ComplicationsAcute Coronary Syndrome+6 more
Miodrag Filipovic, Prof. Dr. med. 458
Post-approval studies (Phase 4)UnknownNCT00825773
What this trial is testing

Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions

Who this might be right for
IschemiaCardiac DeathMyocardial Infarction
JW Medical Systems Ltd 1,944
Not applicableStudy completedNCT03793582
What this trial is testing

Impact of OSA on Outcomes in Acute Coronary Syndrome

Who this might be right for
OSAACS - Acute Coronary SyndromeMajor Adverse Cardiac Events
MetroHealth Medical Center 128
Not applicableStudy completedNCT06884436
What this trial is testing

Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）

Who this might be right for
Major Adverse Cardiac EventsAcute Myocardial Infarction (AMI)Cardiac Death, Sudden+4 more
Chinese PLA General Hospital 22,000
Not applicableWithdrawnNCT06257628
What this trial is testing

MACE CDS Software Master Enrollment Protocol

Who this might be right for
Cardiac Events
Beckman Coulter, Inc.
Early research (Phase 1)Ended earlyNCT00868855
What this trial is testing

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Vanderbilt University 16
Not applicableActive Not RecruitingNCT03466151
What this trial is testing

RESOLUTE ONYX China RCT Study

Who this might be right for
Ischemic Heart DiseaseStenotic Coronary LesionCardiovascular Diseases+2 more
Medtronic Vascular 550
Large-scale testing (Phase 3)Study completedNCT02586155
What this trial is testing

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
Resverlogix Corp 2,425
Not applicableStudy completedNCT01707459
What this trial is testing

The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery

Who this might be right for
Thrombosis
University Health Network, Toronto 201
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,082
Not applicableLooking for participantsNCT07374263
What this trial is testing

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

Who this might be right for
Acquired Long QTVentricular ArrhythmiasTorsades de Pointes+3 more
St. Joseph's Healthcare Hamilton 990,000
Large-scale testing (Phase 3)Study completedNCT01000727
What this trial is testing

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Who this might be right for
Acute Coronary Syndrome
GlaxoSmithKline 13,026
Not applicableWithdrawnNCT04139655
What this trial is testing

Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study

Who this might be right for
Myocardial InfarctionMyocardial InjuryMajor Adverse Cardiac Events+1 more
University of British Columbia
Not applicableLooking for participantsNCT07020858
What this trial is testing

FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion

Who this might be right for
Chronic Total Occlusion (CTO)Chronic Coronary Syndrome
Lin Zhao 470
Not applicableStudy completedNCT01358422
What this trial is testing

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery

Who this might be right for
BleedingThrombosisCardiac Events
European Society of Anaesthesiology 830
Large-scale testing (Phase 3)Looking for participantsNCT06383390
What this trial is testing

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Eli Lilly and Company 10,000
Load More Results